Related Experiment Video
Updated: Jul 30, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
Pediatric autoimmune encephalitis: Recognition and diagnosis
Marienke A A M de Bruijn1, Arlette L Bruijstens1, Anna E M Bastiaansen1
1From the Department of Neurology (M.A.A.M.d.B., A.L.B., A.E.M.B., A.v.S., P.A.E.S.S., M.J.T.), Department of Immunology (M.W.J.S.), and Department of Pediatric Neurology (R.F.N.), Erasmus MC University Medical Center, Rotterdam; Haga Hospital (A.v.S.), The Hague; and Sophia Children's Hospital (R.F.N.), Rotterdam, the Netherlands. A.v.S. is currently working at Medisch Centrum Haaglanden, The Hague.
Insights
Autoimmune encephalitis (AIE) and acute disseminated encephalomyelitis (ADEM) are rare in children, with incidence rates of 1.54 and 2.49 per million, respectively. Critical review and specialized consultation are vital for diagnosing pediatric autoimmune neurological disorders.
Area of Science:
- Pediatric Neurology
- Neuroimmunology
- Epidemiology
Background:
- Autoimmune encephalitis (AIE) and acute disseminated encephalomyelitis (ADEM) are inflammatory neurological disorders affecting children.
- Accurate diagnosis is crucial for timely and effective treatment, yet diagnostic challenges persist in pediatric autoimmune neurological disorders.
- Understanding the incidence and diagnostic pitfalls is essential for improving patient outcomes.
Purpose of the Study:
- To determine the incidence of AIE and ADEM in a pediatric population.
- To validate existing clinical criteria for diagnosing AIE in children.
- To identify diagnostic challenges and pitfalls in pediatric autoimmune and inflammatory neurological disorders.
Main Methods:
- Retrospective cohort study of 113 children with suspected autoimmune or inflammatory neurological disorders.
- Inclusion of three patient categories: antibody-mediated AIE, ADEM, and suspected autoimmune etiology.
- Validation of AIE diagnostic guidelines using baseline and follow-up clinical data; review of patient files and final diagnoses.
Main Results:
- The incidence of antibody-mediated AIE was 1.54/million and ADEM was 2.49/million children.
- The current AIE diagnostic guideline proved useful in the pediatric cohort.
- Diagnostic errors occurred, with 22% of initially suspected autoimmune/inflammatory cases lacking supporting evidence upon review.
Conclusions:
- Antibody-mediated AIE and ADEM are the most common autoimmune/inflammatory encephalitides in children; other forms are rare.
- Existing diagnostic criteria for AIE are applicable to pediatric cases.
- Careful data review, comprehensive workup, and consultation with specialized centers are recommended for children with nonspecific neurological symptoms suggestive of autoimmune or inflammatory conditions.
Objective:
The aims of this study were (1) to describe the incidence of autoimmune encephalitis (AIE) and acute disseminated encephalomyelitis (ADEM) in children, (2) to validate the currently used clinical criteria to diagnose AIE, and (3) to describe pitfalls in the diagnosis of pediatric autoimmune (AI) and inflammatory neurologic disorders.
Methods:
This study cohort consists of 3 patient categories: (1) children with antibody-mediated AIE (n = 21), (2) children with ADEM (n = 32), and (3) children with suspicion of an AI etiology of their neurologic symptoms (n = 60). Baseline and follow-up clinical data were used to validate the current guideline to diagnose AIE. In addition, patient files and final diagnoses were reviewed.
Results:
One-hundred three of the 113 included patients fulfilled the criteria of possible AIE. Twenty-one children had antibody-mediated AIE, of whom 19 had anti-N-methyl-D-aspartate receptor (NMDAR), 1 had anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor, and 1 had anti-leucine-rich glioma-inactivated protein 1 encephalitis. Finally, 34 children had ADEM, and 2 children had Hashimoto encephalopathy. Mean incidence rates were 1.54 children/million (95% CI 0.95-2.35) for antibody-mediated AIE and 2.49 children/million (95% CI 1.73-3.48) for ADEM. Of the other 48 children, treating physicians' diagnoses were reviewed. In 22% (n = 6) of children initially diagnosed as having an AI/inflammatory etiology (n = 27), no support for AI/inflammation was found.
Conclusion:
Besides anti-NMDAR encephalitis and ADEM, other AIEs are rare in children. The current guideline to diagnose AIE is also useful in children. However, in children with nonspecific symptoms, it is important to review data critically, to perform complete workup, and to consult specialized neuroinflammatory centers.
Related Concept Videos
Rocky Mountain Spotted Fever
Viral Meningitis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology

